射血分数降低的急性心力衰竭患者的临床特点及危险因素分析
Analysis of Clinical Characteristics and Risk Factors for Acute Heart Failure Patients with Reduced Ejection Fraction
DOI: 10.12677/ACM.2021.118535, PDF,  被引量   
作者: 吴 飞:青岛大学医学院,山东 青岛;王利宏:浙江省人民医院,浙江 杭州
关键词: 急性心力衰竭左心室射血分数临床特点危险因素Acute Heart Failure Left Ventricular Ejection Fraction Clinical Characteristics Risk Factors
摘要: 目的:分析左心室射血分数(LVEF)降低的急性心力衰竭(AHF)患者的临床特点及危险因素。方法:选取浙江省人民医院2019年1月至2020年1月首次入院的AHF患者162例,根据LVEF将患者分为2组,其中LVEF ≤ 40%为射血分数降低组,共94例,LVEF ≥ 50%为射血分数保留组,共68例。记录上述患者基础资料及实验室指标,并随访1年,记录随访期内再住院及死亡人数。比较两组患者的临床资料,采用多因素logistic回归分析射血分数降低的AHF患者的临床特点及再住院的危险因素。结果:射血分数降低组AHF患者收缩压、尿酸、高密度脂蛋白胆固醇均明显低于射血分数保留组的AHF患者(均P < 0.05),舒张压、心率、糖化血红蛋白A1、白蛋白、脑利钠肽、脑钠素N端前体肽、肌钙蛋白I水平均明显高于射血分数保留组的AHF患者(均P < 0.05);射血分数降低组AHF患者再住院率及1年内死亡率高于射血分数保留组(均P < 0.05)。多因素logistic回归分析发现性别、年龄、心率、白蛋白、糖化血红蛋白A1、脑利钠肽是影响射血分数降低的AHF患者再住院的独立危险因素(均P < 0.05)。结论:左心室射血分数减少的AHF患者的1年内预后较射血分数保留的AHF患者差,临床上应加强对该类患者的随访,改善血压、心率的控制水平,定期监测白蛋白、糖化血红蛋白A1、脑利钠肽、脑钠素N端前体肽水平,降低再住院及死亡率。
Abstract: Objective: Analysis of clinical characteristics and risk factors for acute heart failure (AHF) patients with reduced ejection fraction. Methods: The AHF patients admitted to Zhejiang Provincial People’s Hospital from January 2019 to January 2020 were selected and divided into a reduced ejection fraction group of 94 cases and a reserved ejection fraction group of 68 cases according to the number of admissions. The above patient basic information and laboratory indicators were recorded, followed up for 1 year, recorded in the recycling period and the number of deaths during the period. The clinical data of the two groups of patients were compared and used multivariate logistic regression to analyze influencing factors of rehospitalization of AHF patients with reduced ejection fraction. Results: The systolic blood pressure, uric acid and high density lipoprotein cholesterol of the reduced ejection fraction group were significantly lower than those of the reserved ejection fraction group (all P < 0.05). Diastolic blood pressure, heart rate, glycated hemoglobin A1, albumin, brain sodium peptide, sodium sodium N-end peptide, troponin I of the reduced ejection fraction group were significantly higher than those of the reserved ejection fraction group (all P < 0.05). The rehospitalization rate and the one-year mortality in the 1 year of the mortality of AHF patients in reduced ejection fraction group were higher than that of reserved ejection fraction group (P < 0.05). Multivariate logistic regression analysis shows that gender, age, heart rate, albumin, glycalated hemoglobin A1, brain sodium peptide are independent risk factors that affect the rehospitalization of AHF patients in reduced ejection fraction group. Conclusion: Acute heart failure patients with reduced ejection fraction have poor prognosis within 1 year than patients with reserved ejection fraction. The clinical should strengthen the follow-up of this class and improve blood pressure, heart rate control level, regular monitoring albumin, glycated hemoglobin A1, brain sodium peptide, sodium sodium N-ternary peptide level, reducing re-hospitalization and mortality.
文章引用:吴飞, 王利宏. 射血分数降低的急性心力衰竭患者的临床特点及危险因素分析[J]. 临床医学进展, 2021, 11(8): 3652-3658. https://doi.org/10.12677/ACM.2021.118535

参考文献

[1] Mentz, R.J. and O’connor, C.M. (2016) Pathophysiology and Clinical Evaluation of Acute Heart Failure. Nature Reviews Cardiology, 13, 28-35. [Google Scholar] [CrossRef] [PubMed]
[2] Brandon Stacey, R., Meng, M., Byrum, I.G., et al. (2016) Clinical Outcomes in Different Types of Aortic Stenosis as Assessed by Doppler Echocardiography. The Journal of Heart Valve Disease, 25, 672-678.
[3] 张健, 张宇辉. 多中心、前瞻性中国心力衰竭注册登记研究——病因、临床特点和治疗情况初步分析[J]. 中国循环杂志, 2015, 30(5): 413-416.
[4] 王华, 梁延春. 中国心力衰竭诊断和治疗指南2018 [J]. 中华心血管病杂志, 2018, 46(10): 760-789.
[5] Ponikowski, P., Voors, A.A., Anker, S.D., et al. (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Revista Española de Cardiología (English Edition), 69, 1167.
[6] Kurmani, S. and Squire, I. (2017) Acute Heart Failure: Definition, Classification and Epidemiology. Current Heart Failure Reports, 14, 385-392. [Google Scholar] [CrossRef] [PubMed]
[7] Mosterd, A. and Hoes, A.W. (2007) Clinical Epidemiology of Heart Failure. Heart, 93, 1137-1146. [Google Scholar] [CrossRef] [PubMed]
[8] Emdin, C., Hsiao, A., Kiran, A., et al. (2017) Referral for Specialist Follow-Up and Its Association with Post-discharge Mortality among Patients with Systolic Heart Failure (from the National Heart Failure Audit for England and Wales). The American Journal of Cardiology, 119, 440-444. [Google Scholar] [CrossRef] [PubMed]
[9] Lin, Y., Huang, W., Wu, H., et al. (2021) Association of Mean and Variability of HbA1c with Heart Failure in Patients with Type 2 Diabetes. Journal of Clinical Medicine, 10, 1401. [Google Scholar] [CrossRef] [PubMed]
[10] 朱广明. 急性心力衰竭患者血浆BNP水平与心功能及预后的相关性分析[J]. 中国医药指南, 2019, 17(29): 35.
[11] Nishikimi, T. and Nakagawa, Y. (2019) Does Impaired Processing of Pro-B-Type (or Brain) Natriuretic Peptide Cause Decreased Plasma BNP Levels in Obese Heart Failure Patients? Annals of Translational Medicine, 7, S221. [Google Scholar] [CrossRef] [PubMed]
[12] 陈业媛, 郑泳森, 柏立辉. 老年急性心力衰竭患者血清NT-proBNP水平及APACHEⅡ评分与预后的相关性研究[J]. 临床医学, 2017, 37(1): 7-9.
[13] 曾文莉, 马红梅. 心肌肌钙蛋白I水平联合Tilburg量表对高龄心力衰竭患者预后的判断价值[J]. 心脏杂志, 2020, 32(2): 140-145.
[14] Kontos, M.C. and Turlington, J.S. (2020) High-Sensitivity Troponins in Cardiovascular Disease. Current Cardiology Reports, 22, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[15] Potocnjak, I., Degoricija, V., Trbusic, M., et al. (2017) Serum Concentration of HDL Particles Predicts Mortality in Acute Heart Failure Patients. Scientific Reports, 7, Article ID: 46642. [Google Scholar] [CrossRef] [PubMed]
[16] Degoricija, V., Potocnjak, I., Gastrager, M., et al. (2019) HDL Subclasses and Mortality in Acute Heart Failure Patients. Clinica Chimica Acta, 490, 81-87. [Google Scholar] [CrossRef] [PubMed]
[17] Park, J.J., Park, H.A., Cho, H.J., et al. (2019) Beta-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate. Journal of the American Heart Association, 8, Article ID: e011121. [Google Scholar] [CrossRef
[18] Peterson, E.J., Ng, T.M.H., Patel, K.A., et al. (2018) Association of Admission vs. Nadir Serum Albumin Concentration with Short-Term Treatment Outcomes in Patients with Acute Heart Failure. Journal of International Medical Research, 46, 3665-3674. [Google Scholar] [CrossRef] [PubMed]
[19] Peng, W., Zhang, C., Wang, Z., et al. (2019) Prediction of All-Cause Mortality with Hypoalbuminemia in Patients with Heart Failure: A Meta-Analysis. Biomarkers, 24, 631-637. [Google Scholar] [CrossRef
[20] Al-Lawati, J.A., Sulaiman, K.J., Al-Zakwani, I., et al. (2017) Systolic Blood Pressure on Admission and Mortality in Patients Hospitalized With Acute Heart Failure: Observations from the Gulf Acute Heart Failure Registry. Angiology, 68, 584-591. [Google Scholar] [CrossRef] [PubMed]
[21] 毕祥云, 陈学香, 包振明. 舒张压与80岁以上高血压病人心力衰竭的关系[J]. 实用老年医学, 2017, 31(10): 938-940.
[22] Wu, X., Chen, M., Wang, K., et al. (2020) Gender Differences in Prognostic Markers of All-Cause Death in Patients with Acute Heart Failure: A Prospective 18-Month Follow-Up Study. Journal of Cardiovascular Translational Research, 13, 97-109. [Google Scholar] [CrossRef] [PubMed]
[23] Shiraishi, Y., Kohsaka, S., Harada, K., et al. (2016) Correlation of Pre- and In-Hospital Systolic Blood Pressure in Acute Heart Failure Patients and the Prognostic Implications—Report from the Tokyo Cardiac Care Unit Network Emergency Medical Service Database. Circulation Journal, 80, 2473-2481. [Google Scholar] [CrossRef